24/7 Patient Assistance: 760-405-8205

Jonathan Goldman, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

  • Bio & Insurance Information
  • Education & Training

    dept_icon

    Stanford University

    Medical School

    dept_icon

    UCSF

    Residency

    dept_icon

    UCLA Medical Center

    Fellowship

  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Ronald Reagan UCLA Medical Center

    Languages: English/Spanish

    (310) 825-9111

    757 Westwood Plaza

    Los Angeles, California 90095

    Read More
  • Publications & Memberships

    Dr. Jonathan Goldman has contributed to 3 publications.

    Effect of Food on the Pharmacokinetics of the Investigational Aurora A Kinase Inhibitor Alisertib (MLN8237) in Patients with Advanced Solid Tumors.

    Falchook, G. S.,Zhou, X.,Venkatakrishnan, K.,Kurzrock, R.,Mahalingam, D.,Goldman, J. W.,Jung, J.,Ullmann, C. D.,Milch, C.,Rosen, L. S.,Sarantopoulos, J.; Drugs R D. 2015 Dec 23.

    See more >>

    Erratum to: Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer.

    Bendell, J. C.,Rosen, L. S.,Mayer, R. J.,Goldman, J. W.,Infante, J. R.,Benedetti, F.,Lin, D.,Mizuguchi, H.,Zergebel, C.,Patel, M. R.; Cancer Chemother. Pharmacol.. 2015 Nov 22.

    See more >>

    Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer.

    Bendell, J. C.,Rosen, L. S.,Mayer, R. J.,Goldman, J. W.,Infante, J. R.,Benedetti, F.,Lin, D.,Mizuguchi, H.,Zergebel, C.,Patel, M. R.; Cancer Chemother. Pharmacol.. 2015 Sep 16.

    See more >>